Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

SUMMARY: The final analysis of this 2-year, randomized, crossover study showed that postmenopausal women with osteoporosis were more adherent, compliant, and persistent with subcutaneous denosumab injections every 6 months than with once-weekly alendronate tablets. After receiving both treatments, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Freemantle, N., Satram-Hoang, S., Tang, E.-T., Kaur, P., Macarios, D., Siddhanti, S., Borenstein, J., Kendler, D. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249211/
https://www.ncbi.nlm.nih.gov/pubmed/21927922
http://dx.doi.org/10.1007/s00198-011-1780-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249211/
https://www.ncbi.nlm.nih.gov/pubmed/21927922
http://dx.doi.org/10.1007/s00198-011-1780-1

Ejemplares similares